Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent Treatment of Children With Sulfadoxine-pyrimethamine for Malaria Control
NCT00167843Phase 4Completed
- Sponsor
- Albert Schweitzer Hospital
- Start
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sulfadoxine + pyrimethamine in malaria (2 arms), sponsored by Albert Schweitzer Hospital. Primary endpoints: Efficacy, Proportion of children with at least one episode of anemia from 3 to 18 months of life and 7 more. Started Dec 2002; status: completed.
02
Drugs
sulfadoxine + pyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00167843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00167843.